A
Avive
Develops an automated external defibrillator and software solutions
About Avive
Avive.life operates in the medical technology sector, specializing in Automated External Defibrillators (AEDs) designed to save lives during sudden cardiac arrest (SCA) incidents. The company offers AED devices with unique features such as rechargeable batteries that never need replacement, reducing long-term costs for users. Avive targets a diverse client base, including individual homeowners, multi-door corporations, and community organizations, aiming to make AEDs accessible and easy to use for everyone. The business model revolves around the sale of AED devices and accessories, supported by comprehensive guides and resources to help customers make informed decisions. Revenue is generated through direct sales of AED units, accessories, and possibly subscription services for device maintenance and updates. Avive also focuses on strategic, data-driven placement of AEDs and extensive community training programs to maximize the effectiveness of their devices in emergency situations.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Brisbane, United States
- Employees
- 130
- Open positions
- 7
- Dealroom signal
- 85.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Spinout, Wearable, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Apr 2024 | $57M | $226M | Catalyst Health Ventures · Laerdal million lives fund · Questa Capital Management | ↗ |
| SERIES AOther financing | Mar 2022 | $22M | $88M | Laerdal million lives fund · Catalyst Health Ventures · Questa Capital Management | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Avive is 68K monthly website visits, up 9.7% over the last three months. Avive's team grew 14% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
HealthTech Capital
Hippocrates Ventures
Series A4 investors entered at this stage
IrishAngels- LFLaerdal million lives fund
- CVCatalyst Health Ventures
Questa Capital Management
Other known investors1 additional known investor
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Avive on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Avive’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.